COR logo

COR Cencora, Inc.

New York Stock Exchange · Medical - Distribution · Healthcare

$339.09
-2.16 (-0.63%)

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. I…

Market Cap: $64.71Bwww.cencora.com

Price

No data yet.

Social Signal Score

53
5d
50
1 mentions
—
30d
52
12 mentions
—
60d
53
20 mentions
—
90d
55
33 mentions
—
rss: 6 · news: 26 · alphavantage: 1

Analyst Ratings

46 analysts
Buyconsensus
Strong Buy 0Buy 33Hold 12Sell 1Strong Sell 0
Avg price target$364+7.3%
Low $330Median $350High $400
Current Consensus

Revenue

$88.35B+131.48%
$37.15B$54.22B$71.29B$88.35B
Dec 2016Sep 2026

Analyst Estimates

FY2026
$17.89
$17.86–$17.91
7 analysts
FY2027
$19.63+10% YoY
$19.45–$19.82
6 analysts
FY2028
$21.69+10% YoY
$21.46–$22.05
6 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Robert Mauch
Sector
Healthcare
Industry
Medical - Distribution
Employees
49,000
Beta
0.58
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
4.48
www.cencora.com